Why the study?
Neuromuscular blockade from rocuronium can be reversed by sugammadex or neostigmine, but their comparative impact in pediatric patients undergoing surgery under general anesthesia required systematic evaluation.
Does sugammadex improve the speed of reversal of rocuronium-induced neuromuscular blockade compared to neostigmine in pediatric patients 2-12 years old undergoing surgery under general anesthesia?
Does sugammadex improve the speed of reversal of rocuronium-induced neuromuscular blockade compared to neostigmine in pediatric patients 2-12 years old undergoing surgery under general anesthesia?
Sugammadex provides faster reversal of rocuronium-induced neuromuscular blockade than neostigmine in pediatric patients undergoing general anesthesia.
Answers are grounded in this paper and cite their sources.
Supports sugammadex prioritization for pediatric reversal; extends Level 1 evidence to children 2-12 years.
Aim. The neuromuscular blocker has long been used during surgical procedures. The neuromuscular blockade produced by rocuronium can be reversed with sugammadex and neostigmine as reversal agents. This systematic review aims to determine the impact of sugammadex and neostigmine comparison as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anesthesia. Materials and Methods. This review examined recent studies assessing the impact of sugammadex and neostigmine comparison as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anesthesia. Data were searched from Google Scholar, PubMed, Hindawi, Anesthesiology, MEDLINE, and CENTRAL using keywords’ General Anesthesia,’ ‘Reversal Agent,’ ‘Rocuronium for Pediatric Patients,’ ‘Neuromuscular Blockers,’ ‘Sugammadex and Neostigmine,’ ‘Role of Analgesics.’ The review followed PRISMA guidelines. Results. The initial search for publications comparing sugammadex and neostigmine as a reversal agent of rocuronium for pediatric patients yielded 9000 papers, from which 600 were selected. The reviews’ articles were further analyzed to ensure they were pertinent to the Comparative Impact of Reversal Agents (Sugammadex And Neostigmine) of Rocuronium for Pediatric Patients. Around 319 references were examined for their potential applicability to the medical field of anesthesia. A total of 15 articles were included, with preference given to those published from 2014 to 2023 during the last ten years. Conclusion. The particular relaxant-binding medication promptly and successfully alleviates rocuronium-induced neuromuscular blockade in pediatric surgery patients. Considering the study’s outcomes, it can be concluded that sugammadex may restore any level of steroidal muscle relaxant-induced neuromuscular block faster than neostigmine.
No takes yet. Share an insight, caveat, or question.
Abed et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: